Effect of oral contraceptives on adrenocorticotropin and growth hormone secretion following CRH and GHRH administration

A. J. Jacobs, M. J. Odom, R. A. Word, B. R. Carr

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Previous investigations have demonstrated that basal ACTH plasma levels are reduced and that GH levels are either increased or unchanged in women taking oral contraceptives. The purpose of the present investigation was to determine the secretion of ACTH and GH following an intravenous infusion of human corticotropin releasing hormone (CRH) and human growth hormone releasing hormone (GHRH) in control women (N = 8) and in women taking a triphasic oral contraceptive (N = 9). The studies were initiated between 7:00 and 9:00 a.m. and all women were fasting. An intravenous catheter attached to a 3-way stopcock was used for blood sampling and to inject a bolus of CRH and GHRH ( 1μg kg). Plasma samples were frozen immediately and stored at -70 °C until assayed for content of ACTH and GH by radioimmunoassay. The plasma levels of ACTH and GH increased following infusion of CRH and GHRH in all women. The mean plasma levels of growth hormone were not statistically different in oral contraceptive users compared to normal women. In contrast, ACTH plasma levels in oral contraceptive users were reduced approximately 25% overall, and significantly lower (p<0.04) at 120 minutes following the CRH infusion compared to controls. In conclusion, the GHRH-stimulated GH release was similar in normal women and oral contraceptive users. CRH-stimulated ACTH release was modestly reduced in oral contraceptive users compared to normal women suggesting that estrogens and progestogens may have a suppressive effect on the release of ACTH by the pituitary.

Original languageEnglish (US)
Pages (from-to)691-699
Number of pages9
JournalContraception
Volume40
Issue number6
DOIs
StatePublished - 1989

Fingerprint

Growth Hormone-Releasing Hormone
Corticotropin-Releasing Hormone
Oral Contraceptives
Adrenocorticotropic Hormone
Growth Hormone
Human Growth Hormone
Progestins
Intravenous Infusions
Radioimmunoassay
Fasting
Estrogens
Catheters

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Effect of oral contraceptives on adrenocorticotropin and growth hormone secretion following CRH and GHRH administration. / Jacobs, A. J.; Odom, M. J.; Word, R. A.; Carr, B. R.

In: Contraception, Vol. 40, No. 6, 1989, p. 691-699.

Research output: Contribution to journalArticle

@article{58728ee6b44b410cbe5068e2e0160c6a,
title = "Effect of oral contraceptives on adrenocorticotropin and growth hormone secretion following CRH and GHRH administration",
abstract = "Previous investigations have demonstrated that basal ACTH plasma levels are reduced and that GH levels are either increased or unchanged in women taking oral contraceptives. The purpose of the present investigation was to determine the secretion of ACTH and GH following an intravenous infusion of human corticotropin releasing hormone (CRH) and human growth hormone releasing hormone (GHRH) in control women (N = 8) and in women taking a triphasic oral contraceptive (N = 9). The studies were initiated between 7:00 and 9:00 a.m. and all women were fasting. An intravenous catheter attached to a 3-way stopcock was used for blood sampling and to inject a bolus of CRH and GHRH ( 1μg kg). Plasma samples were frozen immediately and stored at -70 °C until assayed for content of ACTH and GH by radioimmunoassay. The plasma levels of ACTH and GH increased following infusion of CRH and GHRH in all women. The mean plasma levels of growth hormone were not statistically different in oral contraceptive users compared to normal women. In contrast, ACTH plasma levels in oral contraceptive users were reduced approximately 25{\%} overall, and significantly lower (p<0.04) at 120 minutes following the CRH infusion compared to controls. In conclusion, the GHRH-stimulated GH release was similar in normal women and oral contraceptive users. CRH-stimulated ACTH release was modestly reduced in oral contraceptive users compared to normal women suggesting that estrogens and progestogens may have a suppressive effect on the release of ACTH by the pituitary.",
author = "Jacobs, {A. J.} and Odom, {M. J.} and Word, {R. A.} and Carr, {B. R.}",
year = "1989",
doi = "10.1016/0010-7824(89)90072-3",
language = "English (US)",
volume = "40",
pages = "691--699",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Effect of oral contraceptives on adrenocorticotropin and growth hormone secretion following CRH and GHRH administration

AU - Jacobs, A. J.

AU - Odom, M. J.

AU - Word, R. A.

AU - Carr, B. R.

PY - 1989

Y1 - 1989

N2 - Previous investigations have demonstrated that basal ACTH plasma levels are reduced and that GH levels are either increased or unchanged in women taking oral contraceptives. The purpose of the present investigation was to determine the secretion of ACTH and GH following an intravenous infusion of human corticotropin releasing hormone (CRH) and human growth hormone releasing hormone (GHRH) in control women (N = 8) and in women taking a triphasic oral contraceptive (N = 9). The studies were initiated between 7:00 and 9:00 a.m. and all women were fasting. An intravenous catheter attached to a 3-way stopcock was used for blood sampling and to inject a bolus of CRH and GHRH ( 1μg kg). Plasma samples were frozen immediately and stored at -70 °C until assayed for content of ACTH and GH by radioimmunoassay. The plasma levels of ACTH and GH increased following infusion of CRH and GHRH in all women. The mean plasma levels of growth hormone were not statistically different in oral contraceptive users compared to normal women. In contrast, ACTH plasma levels in oral contraceptive users were reduced approximately 25% overall, and significantly lower (p<0.04) at 120 minutes following the CRH infusion compared to controls. In conclusion, the GHRH-stimulated GH release was similar in normal women and oral contraceptive users. CRH-stimulated ACTH release was modestly reduced in oral contraceptive users compared to normal women suggesting that estrogens and progestogens may have a suppressive effect on the release of ACTH by the pituitary.

AB - Previous investigations have demonstrated that basal ACTH plasma levels are reduced and that GH levels are either increased or unchanged in women taking oral contraceptives. The purpose of the present investigation was to determine the secretion of ACTH and GH following an intravenous infusion of human corticotropin releasing hormone (CRH) and human growth hormone releasing hormone (GHRH) in control women (N = 8) and in women taking a triphasic oral contraceptive (N = 9). The studies were initiated between 7:00 and 9:00 a.m. and all women were fasting. An intravenous catheter attached to a 3-way stopcock was used for blood sampling and to inject a bolus of CRH and GHRH ( 1μg kg). Plasma samples were frozen immediately and stored at -70 °C until assayed for content of ACTH and GH by radioimmunoassay. The plasma levels of ACTH and GH increased following infusion of CRH and GHRH in all women. The mean plasma levels of growth hormone were not statistically different in oral contraceptive users compared to normal women. In contrast, ACTH plasma levels in oral contraceptive users were reduced approximately 25% overall, and significantly lower (p<0.04) at 120 minutes following the CRH infusion compared to controls. In conclusion, the GHRH-stimulated GH release was similar in normal women and oral contraceptive users. CRH-stimulated ACTH release was modestly reduced in oral contraceptive users compared to normal women suggesting that estrogens and progestogens may have a suppressive effect on the release of ACTH by the pituitary.

UR - http://www.scopus.com/inward/record.url?scp=0024806766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024806766&partnerID=8YFLogxK

U2 - 10.1016/0010-7824(89)90072-3

DO - 10.1016/0010-7824(89)90072-3

M3 - Article

VL - 40

SP - 691

EP - 699

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 6

ER -